| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | -1.4% |
| R&D Expense | $39.5M | -8.7% |
| SG&A Expense | $18.6M | -5.1% |
| Operating Income | -$48.3M | +8.8% |
| Net Income | -$47.4M | +16.3% |
| EPS (Basic) | -$8.96 | -1568.9% |
| EPS (Diluted) | -$8.96 | -1568.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.7M | +35.7% |
| Short-term Investments | $29.7M | -55.0% |
| Accounts Receivable | $2.8M | -6.1% |
| Current Assets | $60.9M | -33.9% |
| Total Assets | $77.3M | -29.0% |
| Current Liabilities | $13.5M | +35.0% |
| Total Liabilities | $57.6M | -7.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.4M | +29.3% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $37.8M | +14.4% |
| Financing Cash Flow | $7.6M | +774.3% |
| Free Cash Flow | -$38.4M | +29.8% |
| Stockholders' Equity |
| $19.7M |
| -57.7% |